Clinical Trials Browser

toripalimab × Tumor-Agnostic × 1 year × Clear all

NCT05707910 2026-03-09

Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

Phase 1 Active not recruiting

Neoplasms

NCT07004244 2025-06-24

Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies

Phase 1 Recruiting

Neoplasms

NCT04991506 2025-06-23

A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms